China's Zai Lab files for $115m Nasdaq listing
Chinese biopharmaceutical firm Zai Lab has made its plans for a $115m IPO of American Depositary Shares (ADSs) public, filing a draft prospectus with the US regulator on Tuesday.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: